RecruitingNot Applicable

Model-informed Individualized Treatment of Anti-infective Drugs

China300 participantsStarted 2024-10-12

Plain-language summary

The study aims to optimize individualized treatment of anti-infective drugs in osteoarticular infections by analyzing drug exposure in patients blood and/or tissues using population pharmacokinetics.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with suspected/confirmed osteoarticular infections who are undergoing anti-infective drug therapy. Exclusion Criteria: * Pregnant/lactating women. * There are other factors that the researchers think are not suitable for inclusion.

What they're measuring

Clearance (L/h)

Timeframe: Through study completion, an average of 30 days

Volume of Distribution (L)

Timeframe: Through study completion, an average of 30 days

Trial details

NCT IDNCT06711562

SponsorShandong University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-10-01

Contact for this trial

Wei Zhao, Ph.D

86053188383308 zhao4wei2@hotmail.com

View on ClinicalTrials.gov More Osteoarticular Infections trials